Contracts Finder · Tender
Purchase of Mass Array
A public procurement published by MHRA Buyer Organisation via Contracts Finder.
- —
- Award value
- £100k
- Tender value
- 0
- Suppliers
- 0
- Awards
- 2
- Notices
- Tender
- Stage
Overview
The Agency is looking to purchase a new integrated, substantially automated platform capable of performing mid-throughput SNP genotyping, DNA Methylation analysis, Quantitative Gene Expression Analysis and Allele frequency determination on pooled samples of DNA. The system will be utilising a mass-spectrometry spectral analysis approach to complement pre-existing in-house digital PCR and NGS capabilities. The system must be capable of routinely achieving the stated number SNP genotyping per run. The order must be financially committed by NIBSC/ MHRA before 31st March 2023. Submit response via Atamis e-procurement portal (https://health-family.force.com/s/Welcome)
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Tender
- Status
- active
- CPV classification
- 38000000 — Laboratory, optical and precision equipments (excl. glasses)
- Currency
- GBP
- Total award value
- —
- Tender value
- £100,000
- First published
- 12 Oct 2022
- Last updated
- 13 Oct 2022
Notice timeline
Every published notice in this procurement's lifecycle.
Frameworks & programmes
More from MHRA Buyer Organisation
FAQs about this procurement
Who is the buyer for "Purchase of Mass Array"?
Purchase of Mass Array is a UK public-sector procurement published by MHRA Buyer Organisation via Contracts Finder.
Has "Purchase of Mass Array" been awarded?
No award has been recorded yet. The current lifecycle stage is "Tender".
What is "Purchase of Mass Array" worth?
The reported tender value is £100,000.
When was "Purchase of Mass Array" published?
It was first published on 12 Oct 2022 and last updated on 13 Oct 2022, across 2 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable